RCT of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities
This study is ongoing, but not recruiting participants.
Sponsor:
University of California, Davis
Collaborators:
University of Rochester
The City University of New York
Information provided by (Responsible Party):
Anthony F. Jerant, University of California, Davis
ClinicalTrials.gov Identifier:
NCT00786747
First received: November 5, 2008
Last updated: April 24, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study investigators have developed an interactive multimedia computer program that provides personally tailored education about colorectal cancer screening in the user's preferred language (English or Spanish). In this study, the investigators will examine whether use of the computer program increases the number of Hispanic patients who receive colorectal cancer screening and lessens or eliminates the glaring disparity in screening between Hispanics and non-Hispanic whites.
| Condition | Intervention |
|---|---|
|
Colorectal Neoplasms |
Behavioral: Personally tailored computer program Behavioral: Non-tailored control computer program |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Screening |
| Official Title: | Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities |
Resource links provided by NLM:
Further study details as provided by University of California, Davis:
Primary Outcome Measures:
- Up to date colorectal cancer screening status [ Time Frame: 1 year ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Up to date colonoscopy screening status [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Up to date fecal occult blood testing status [ Time Frame: 1 year ] [ Designated as safety issue: No ]
- Colorectal cancer screening self-efficacy [ Time Frame: Immediately after computer program use ] [ Designated as safety issue: No ]
- Perceived barriers to colorectal cancer screening [ Time Frame: Immediately after computer program use ] [ Designated as safety issue: No ]
- Readiness to undergo colorectal cancer screening [ Time Frame: Immediately after computer program use ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 1344 |
| Study Start Date: | February 2010 |
| Estimated Study Completion Date: | October 2012 |
| Primary Completion Date: | October 2011 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Personally tailored computer program
The experimental computer program provides the user with information about colorectal cancer screening that is tailored to their self-efficacy, readiness, and perceived barriers to undergoing screening, in their preferred language (English or Spanish).
|
Behavioral: Personally tailored computer program
The experimental computer program provides the user with information about colorectal cancer screening that is tailored to their self-efficacy, readiness, and perceived barriers to undergoing screening, in their preferred language (English or Spanish).
|
|
Active Comparator: Non-tailored control computer program
This program provides non-tailored, generic information about colorectal cancer screening, in the user's preferred language (English or Spanish).
|
Behavioral: Non-tailored control computer program
This program provides users with non-tailored information about colorectal cancer screening, in their preferred language (English or Spanish).
|
Detailed Description:
- Background: Interactive multimedia computer programs (IMCPs) show promise as a way of delivering personally tailored (PT) information to enhance cognitive mediators of health behavior and improve patient outcomes. However, it is unclear whether PT IMCPs can be deployed in primary care offices to increase cancer screening uptake and eliminate ethnic disparities in uptake by providing PT information in each user's preferred language.
- Aims/Hypotheses: We will compare changes in colorectal cancer (CRC) screening cognitive mediators (self-efficacy, perceived barriers, and readiness) and uptake resulting from an IMCP - PT to enhance the key cognitive mediators and targeted to patients' self-identified ethnicity - with changes resulting from a non-tailored "electronic leaflet" control IMCP. The experimental and control IMCPs will each be offered in English and Spanish versions. We hypothesize that, compared with the appropriate control condition (English, Spanish, or both combined): (1) the English version of the PT IMCP will enhance the cognitive mediators of CRC screening behavior for English-speaking Hispanics and non-Hispanics; (2) there will be similarly favorable changes in these mediators for Hispanics using the Spanish version of the PT IMCP; (3) deployment of the PT IMCP will provide evidence of elimination of disparities in CRC screening between Hispanic and non-Hispanic subjects via its relative impact on the cognitive mediators in these groups; and (4) the PT IMCP (English and Spanish combined) will increase CRC screening uptake in Hispanics and non-Hispanics (considered separately) via changes in the cognitive mediators.
- Methods: Randomized controlled trial of 2 groups, comparing a PT (to the cognitive mediators) CRC screening IMCP offered in both English and Spanish versions and deployed before a primary care office visit with a non-tailored "electronic leaflet" CRC screening IMCP (control) also offered in both English and Spanish. Screening methods targeted will be fecal occult blood testing, flexible sigmoidoscopy, and colonoscopy. Primary outcomes will be CRC screening uptake, self-efficacy, perceived barriers, and readiness.
- Implications: Our findings will determine whether an IMCP that is PT to cognitive mediators of screening behavior and deployed in primary care offices prior to previously scheduled visits can activate patients of various ethnicities to undergo CRC screening. They may also suggest a promising, portable method of reducing disparities in CRC (and other) screening uptake between Hispanic and non-Hispanic individuals.
Eligibility| Ages Eligible for Study: | 50 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Receive primary care at one of the participating outpatient study offices
- Age at or above 50 years
- Able to read and speak English and/or Spanish
- Adequate vision, hearing, and hand function to use an IMCP running on a laptop computer via a touch screen interface
- Have an active telephone
- Not up to date for CRC screening. Up to date status will be defined as having completed CRC screening via: FOBT within 2 years; FS within 5 years; or colonoscopy within 10 years, consistent with national practice guidelines and standards.
Exclusion Criteria:
- Unable to understand the consent form or the telephone screening questionnaire due to cognitive impairment
- Unable to provide informed consent due to serious acute illness
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00786747
Locations
| United States, California | |
| University of California, Davis Health System | |
| Sacramento, California, United States, 95817 | |
| United States, Colorado | |
| University of Colorado | |
| Aurora, Colorado, United States, 80045 | |
| United States, New York | |
| Sophie Davis School of Biomedical Education, City University of New York, | |
| New York City, New York, United States, 10031 | |
| University of Rochester School of Medicine and Dentistry | |
| Rochester, New York, United States, 14642 | |
| United States, Texas | |
| University of Texas Health Sciences Center | |
| San Antonio, Texas, United States, 78229 | |
Sponsors and Collaborators
University of California, Davis
University of Rochester
The City University of New York
Investigators
| Principal Investigator: | Anthony Jerant, MD | University of California, Davis |
More Information
Additional Information:
No publications provided
| Responsible Party: | Anthony F. Jerant, Professor, University of California, Davis |
| ClinicalTrials.gov Identifier: | NCT00786747 History of Changes |
| Other Study ID Numbers: | NCI -1R01CA131386-01A1, ARRA CA13138602S1 |
| Study First Received: | November 5, 2008 |
| Last Updated: | April 24, 2012 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, Davis:
|
Computer-assisted instruction Health knowledge, attitudes, practice Mass screening Patient acceptance of health care |
Patient education as topic Primary health care Self-efficacy |
Additional relevant MeSH terms:
|
Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 23, 2013